Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
TCM Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

NT$60.2

2024-10-29

Market Capitalization

NT$3.6 B

2024-10-29

Revenue

NT$685.5 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

TWDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue540.2M568.6M737.1M702.0M802.4M969.6M666.5M685.5M
Cost of goods sold267.3M279.4M353.1M325.3M333.9M467.6M315.4M345.0M
Gross profit274.7M290.3M384.2M377.5M468.6M502.3M363.6M340.7M
Gross profit margin, %51.0%52.1%53.8%58.4%51.8%54.6%49.7%
Operating expense total228.7M259.8M331.1M356.6M422.7M457.8M317.3M299.0M
Depreciation and amortization12.5M15.9M15.1M18.1M20.0M21.9M23.9M23.5M
EBITDA46.0M30.5M53.0M20.9M45.9M44.5M46.3M41.8M
EBITDA margin, %5.4%7.2%3.0%5.7%4.6%6.9%6.1%
EBIT33.5M14.8M39.3M3.7M25.9M23.3M21.2M16.8M
EBIT margin, %2.6%5.3%0.5%3.2%2.4%3.2%2.5%
Interest income537.0K95.0K68.0K41.0K138.0K1.5M4.7M5.7M
Interest expense1.9M1.9M2.0M2.4M2.8M1.6M864.0K
Pre tax profit32.2M12.9M36.1M2.3M23.1M22.0M25.0M22.3M
Income tax expense7.4M6.4M10.6M384.0K4.9M3.5M4.0M3.1M
Net Income24.8M6.5M25.5M1.9M18.3M18.6M21.0M19.2M

Footer menu